Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis
I. Arias de la Rosa(Instituto Maimónides de Investigación Biomédica de Córdoba), Nuria Barbarroja(Instituto Maimónides de Investigación Biomédica de Córdoba), Lourdes Ladehesa-Pineda(Instituto Maimónides de Investigación Biomédica de Córdoba), Carmen Castro(Instituto Maimónides de Investigación Biomédica de Córdoba), J. Calvo-Gutiérrez(Instituto Maimónides de Investigación Biomédica de Córdoba), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), R. Ortega Castro(Instituto Maimónides de Investigación Biomédica de Córdoba), Carmen Torres-Granados(Instituto Maimónides de Investigación Biomédica de Córdoba), Eduardo Collantes‐Estévez(Hospital Universitario Reina Sofía), C. López-Pedrera(Instituto Maimónides de Investigación Biomédica de Córdoba), Yolanda Jiménez(Instituto Maimónides de Investigación Biomédica de Córdoba), M. Luque-Tévar(Instituto Maimónides de Investigación Biomédica de Córdoba), Alejandro Escudero‐Contreras(Instituto Maimónides de Investigación Biomédica de Córdoba), A. M. Patiño-Trives(Instituto Maimónides de Investigación Biomédica de Córdoba), María Dolores López-Montilla(Instituto Maimónides de Investigación Biomédica de Córdoba), Pilar Font(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cited by 22
Related Papers
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
|Nature Communications|2021|166
Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome
|Journal of Thrombosis and Haemostasis|2011|120
Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
|Cancer Letters|2015|91
Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight
|Journal of Endocrinology|2013|88
A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic Implications
|The Journal of Clinical Endocrinology & Metabolism|2013|81